COMMUNIQUÉS West-GlobeNewswire

Biome Grow Secures Sales License for Nova Scotia Subsidiary-- CFN Media
19/12/2018
SEATTLE, Dec. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Avricore Health Signs Letter of Intent with Molecular You to Further Enhance the HealthTab Platform with Tests Designed to Ensure Safe Cannabis Use
19/12/2018
VANCOUVER, British Columbia, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR) (“ Avricore Health ”) is pleased to announce that it has signed a Letter of Intent (LOI) with Molecular You Corporation [...]
Hemispherx Biopharma Inc. Announces First Large Ampligen Shipment to a Clinical Site for Use in U.S. Expanded Access Program
19/12/2018
OCALA, Fla., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in immunology, shipped 720 [...]
Resverlogix Announces Eighth Positive Data Safety Monitoring Board Recommendation For Phase 3 Study of Apabetalone
19/12/2018
BETonMACE trial to continue as planned without modification CALGARY, Alberta, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) today announces the independent Data and [...]
NexTech Launches Ecommerce AR Solution for Shopify, Magento & WordPress -- CFN Media
19/12/2018
SEATTLE, Dec. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Melinta Therapeutics Announces Commitment for New Credit Facility of Up to $135 Million
19/12/2018
~ Credit Facility has Option to be Converted into Preferred Shares ~ ~ Adjourns Special Meeting of Stockholders Scheduled for December 20, 2018 ~ ~ Reaffirms Product Sales and Cost Savings Guidance ~ NEW HAVEN, Conn., [...]
Tabula Rasa HealthCare Appoints Kevin Boesen as Chief Sales Officer
19/12/2018
MOORESTOWN, N.J., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced the appointment of [...]
Equillium Granted U.S. FDA Fast Track Designation for EQ001 for the Treatment of Acute Graft-Versus-Host Disease
19/12/2018
Company plans to initiate Phase 1b/2 EQUATE clinical trial in early 2019 LA JOLLA, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immuno- [...]
Evolus Added to NASDAQ Biotechnology Index
19/12/2018
IRVINE, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced that the company has been selected for addition to the NASDAQ Biotechnology Index [...]
Spectral to Attend the 37th Annual J.P. Morgan Healthcare Conference
19/12/2018
TORONTO, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:EDT) , a Phase III company developing the first treatment for patients with endotoxemic septic shock guided by a [...]
Nemaura to Host Investor Webinar on December 21 to Provide Update on Recent Developments
19/12/2018
LOUGHBOROUGH, England - Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes [...]
Krystal Biotech Completes Dosing in the GEM-Phase 2 Study in Pediatric Patients for the Treatment of Dystrophic Epidermolysis Bullosa
19/12/2018
Top line results from GEM-Phase 2 study expected in H1 2019 PITTSBURGH, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company developing topical and intradermal "off [...]
AMAG Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference
19/12/2018
WALTHAM, Mass., Dec. 19, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that William Heiden, president and chief executive officer, will present at the 37 th Annual J.P. Morgan [...]
Johnson & Johnson's Biosense Webster’s MaryAnn Edzards Joins BioSig
19/12/2018
Former New Technology Education Manager to Assist with First Installations Santa Monica, CA, Dec. 19, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a [...]
resTORbio Appoints William Marshall, M.D., as Vice President of Medical Sciences
19/12/2018
BOSTON, Dec. 19, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq:TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of novel [...]
RTI Donor Services and Versiti Celebrate the Gift of Tissue Donation with Donate Life Float in 2019 Rose Parade®
19/12/2018
RTI Donor Services sponsors tissue recipient as walker on float MILWAUKEE, Dec. 19, 2018 (GLOBE NEWSWIRE) -- RTI Donor Services (RTIDS), a nonprofit organization dedicated to providing responsible stewardship of the [...]
Allogene Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference
19/12/2018
SOUTH SAN FRANCISCO, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for [...]
Immunomedics To Present at the 37th Annual J.P. Morgan Healthcare Conference
19/12/2018
MORRIS PLAINS, N.J., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates, today announced [...]
Avenue Therapeutics Announces Dosing of First Patient in Second Pivotal Phase 3 Clinical Trial of Intravenous Tramadol for the Management of Postoperative Pain
19/12/2018
Topline data readout expected in mid-2019 NEW YORK, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a specialty pharmaceutical company focused on the development and [...]

Pages